Your Followed Topics

health / medicine7 months ago

https://time.com/7280610/cancer-immunotherapy-dostarlimab-andrea-cercek/https://www.nbcnews.com/health/cancer/cancer-patients-immunotherapy-may-way-skip-surgery-chemo-rcna203038https://www.nytimes.com/2025/04/27/health/cancer-immunotherapy-solid-tumors.html
Time.com and 5 more
time.com
Open in Time.com
Highlights
  • Pembrolizumab before and after surgery improves 3-year survival for head and neck cancer patients.
  • Studies show immunotherapy reduces metastasis and may allow some patients to avoid invasive surgery.
  • Regulators are reviewing pembrolizumab, with potential wider use by mid-2025 for resectable head and neck cancers.
Vote 5
0

References

A New Immune Treatment May Work Against Several Cancer Types

A New Immune Treatment May Work Against Several Cancer Types

For some cancer patients, immunotherapy may be way to skip surgery and chemo

For some cancer patients, immunotherapy may be way to skip surgery and chemo

Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies

Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies

New treatment may add years to life of head and neck cancer patients

New treatment may add years to life of head and neck cancer patients

New Standard of Care in Locally Advanced Head, Neck Cancer?

New Standard of Care in Locally Advanced Head, Neck Cancer?

Related Topics

0 Comments

Be the first to comment

Add your thoughts and get the conversation going.

Top 590 Internet News Today

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement